These findings suggest that CPSF6 enhances the Warburg effect and angiogenesis, leading to cancer progression via c-Myc mediated by the FBW7 signaling axis, with its siRNA synergistic effect with sorafenib as a molecular target for liver cancer therapy. The gene discussed is MYC; the disease is liver cancer.